Literature DB >> 8318417

Ischemia and loss of ATP in tumours following treatment with focused high energy shock waves.

M Dellian1, S Walenta, F Gamarra, G E Kuhnle, W Mueller-Klieser, A E Goetz.   

Abstract

High energy shock waves (HESW) have been reported to be cytotoxic to tumour cells in vitro and in vivo. For that reason they are evaluated as a new modality for cancer treatment. In the present study we have quantified the effect of treatment with multifocal HESW on tumour blood flow and energy status. Blood flow and adenosine triphosphate (ATP) concentration were investigated simultaneously in tumour and adjacent tissue of six treated and six untreated amelanotic hamster melanomas (A-Mel-3) at 3, 12 or 24 h after multifocal application of HESW. 14C-iodoantipyrine autoradiography for blood flow measurements and quantitative ATP imaging bioluminescence were employed. Following treatment, tumour blood flow and ATP concentration were significantly reduced, as compared to control, over the entire period of observation. Three hours after HESW, blood flow and ATP concentration were at the background level. In adjacent tissue, blood flow and ATP concentration were distinctly diminished. We therefore conclude that multifocal HESW induce a breakdown of tumour-, and adjacent tissue perfusion which is accompanied by a significant decrease of intracellular ATP concentration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318417      PMCID: PMC1968310          DOI: 10.1038/bjc.1993.281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Transplantable tumors of the Syrian (golden) hamster. I. Tumors of the alimentary tract, endocrine glands and melanomas.

Authors:  J G FORTNER; A G MAHY; G R SCHRODT
Journal:  Cancer Res       Date:  1961-07       Impact factor: 12.701

2.  Effects of high-energy shock waves combined with biological response modifiers or Adriamycin on a human kidney cancer xenograft.

Authors:  G O Oosterhof; G A Smiths; J E deRuyter; J A Schalken; F M Debruyne
Journal:  Urol Res       Date:  1990

3.  Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.

Authors:  F Kallinowski; K H Schlenger; S Runkel; M Kloes; M Stohrer; P Okunieff; P Vaupel
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

Review 4.  The effect of therapy on tumour vascular function.

Authors:  D J Chaplin
Journal:  Int J Radiat Biol       Date:  1991 Jul-Aug       Impact factor: 2.694

5.  First clinical experience with extracorporeally induced destruction of kidney stones by shock waves.

Authors:  C Chaussy; E Schmiedt; D Jocham; W Brendel; B Forssmann; V Walther
Journal:  J Urol       Date:  1982-03       Impact factor: 7.450

6.  Vascular occlusion and tumour cell death.

Authors:  J Denekamp; S A Hill; B Hobson
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

7.  Examination of aggravating factors of urinary excretion of N-acetyl-beta-D-glucosaminidase after extracorporeal shock wave lithotripsy.

Authors:  W Sakamoto; T Kishimoto; T Nakatani; Y Ameno; A Ohyama; M Kamizuru; R Yasumoto; M Maekawa
Journal:  Nephron       Date:  1991       Impact factor: 2.847

Review 8.  The role of lithotripsy and its side effects.

Authors:  J E Lingeman; J Woods; P D Toth; A P Evan; J A McAteer
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

9.  Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting.

Authors:  W Mueller-Klieser; S Walenta; W Paschen; F Kallinowski; P Vaupel
Journal:  J Natl Cancer Inst       Date:  1988-08-03       Impact factor: 13.506

10.  High energy shock waves suppress tumor growth in vitro and in vivo.

Authors:  P Russo; R A Stephenson; C Mies; R Huryk; W D Heston; M R Melamed; W R Fair
Journal:  J Urol       Date:  1986-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.